Regional distribution of parkinsonism-preventing endogenous tetrahydroisoquinoline derivatives and an endogenous parkinsonism-preventing substance-synthesizing enzyme in monkey brain

被引:51
作者
Yamakawa, T
Kotake, Y
Fujitani, M
Shintani, H
Makino, Y
Ohta, S
机构
[1] Hiroshima Univ, Sch Med, Inst Pharmaceut Sci, Minami Ku, Hiroshima 7348551, Japan
[2] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1138605, Japan
[3] Hiroshima Univ, Sch Dent, Dept Operat Dent, Minami Ku, Hiroshima 7348551, Japan
关键词
parkinsonism; 1-methyl-1,2,3,4-tetrahydroisoquinoline-synthesizing enzyme; monkey brain; endogenous tetrahydroisoquinolines; regional distribution in brain; 1-benzyl-1,2,3,4-tetrahydroisoquinoline;
D O I
10.1016/S0304-3940(99)00786-7
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
1,2,3,4-Tetrahydroisoquinoline (TIQ) and 1-benzyl-1,2,3,4-tetrahydroisoquinoline (1BnTIQ), which exist in the brain of several mammalian species, are parkinsonism-inducing substances, and 1-methyl-1,2,3,4-tetrahydroisoquinoline (1MeTIQ), which is enzymatically synthesized in rat brain, is a parkinsonism-preventing substance. in this study, we examined the regional distribution of contents of TIQ, 1MeTIQ, and 1BnTIQ, and activity of 1MeTIQ-synthesizing enzyme in monkey brain. The TIQ and 1BnTIQ contents in cerebrum and substantia nigra, and the 1MeTIQ contents in striatum and substantia nigra were higher than those in other brain regions, and 1MeTIQ-synthetic activity was high in cerebrum and thalamus. We speculate that 1MeTIQ-synthesizing enzyme may play an important role in idiopathic Parkinson's disease. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:68 / 70
页数:3
相关论文
共 16 条
[1]   INDOLE-N-METHYLATED BETA-CARBOLINIUM IONS AS POTENTIAL BRAIN-BIOACTIVATED NEUROTOXINS [J].
COLLINS, MA ;
NEAFSEY, EJ ;
MATSUBARA, K ;
COBUZZI, RJ ;
ROLLEMA, H .
BRAIN RESEARCH, 1992, 570 (1-2) :154-160
[2]   Effect of a pyridinium metabolite derived from haloperidol on the activities of striatal tyrosine hydroxylase in freely moving rats [J].
Igarashi, K ;
Matsubara, K ;
Kasuya, F ;
Fukui, M ;
Idzu, T ;
Castagnoli, N .
NEUROSCIENCE LETTERS, 1996, 214 (2-3) :183-186
[3]  
Kawai H, 1998, J NEUROCHEM, V70, P745
[4]  
KIKUCHI K, 1991, DRUG METAB DISPOS, V19, P257
[5]   TETRAHYDROISOQUINOLINE AND 1-METHYL-TETRAHYDROISOQUINOLINE AS NOVEL ENDOGENOUS AMINES IN RAT-BRAIN [J].
KOHNO, M ;
OHTA, S ;
HIROBE, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1986, 140 (01) :448-454
[6]  
KOTAKE Y, 1995, J NEUROCHEM, V65, P2633
[7]  
Kotake Y, 1996, NEUROSCI LETT, V217, P69
[8]  
LOWRY OH, 1951, J BIOL CHEM, V193, P265
[9]   CONFIRMATION OF THE ENANTIOMERS OF 1-METHYL-1,2,3,4-TETRAHYDROISOQUINOLINE IN THE MOUSE-BRAIN AND FOODS APPLYING GAS-CHROMATOGRAPHY MASS-SPECTROMETRY WITH NEGATIVE-ION CHEMICAL IONIZATION [J].
MAKINO, Y ;
TASAKI, Y ;
OHTA, S ;
HIROBE, M .
BIOMEDICAL AND ENVIRONMENTAL MASS SPECTROMETRY, 1990, 19 (07) :415-419
[10]  
Matsubara K, 1998, J NEUROCHEM, V70, P727